Forecast: Hospital Discharges for Malignant Neoplasm of Ovary in France

The forecast for hospital discharges due to malignant neoplasm of ovary in France shows a gradual decline from 2024 to 2028. The number of discharges begins at 7.07 thousand in 2024, decreasing steadily to 6.84 thousand by 2028. This represents a consistent downward trend over the five-year forecast period.

- From 2024 to 2025, there is a 0.85% decline.

- From 2025 to 2026, the decline is similarly noted at 0.86%.

- Between 2026 and 2027, there is a slight decrease of 0.72%, followed by a 0.87% decline from 2027 to 2028.

- The Compound Annual Growth Rate (CAGR) over these five years is approximately -0.84%.

Future trends to watch for include advances in early detection and treatment options, which may further impact hospital discharges. Monitoring healthcare policies, as well as changes in demographic factors such as population aging, will also be crucial in understanding evolving discharge trends.

Top Countries about Ovarian Cancer